The annual production capacity of high-grade rutile titanium dioxide has reached more than 400,000 tons. It is one of the largest TiO2 manufacturers in China at present. It has more than ten product brands of Taiohua, Jinxing and other brands, and its products are sold in more than 50 countries and regions around the world. It has long maintained the excellent performance of the second overall ranking in the domestic titanium dioxide industry.

For a mini-review published in the journal Particle and Fibre Technology in 2021, scientists wanted to evaluate whether Ti02 particles contributed to the development and/or exacerbation of irritable bowel disease, and whether they altered the four elements of intestinal barrier function: the intestinal microbiota, the immune system, the mucus layer, and the epithelium. The breakdown of these four elements can contribute to autoimmune, neurological, inflammatory, infectious, and metabolic diseases. Following their review, the researchers concluded: “Data indicate that TiO2 is able to alter the four compartments of IBF and to induce a low-grade intestinal inflammation associated or not with pre-neoplastic lesions.” 

There is some concern regarding skin and intestinal absorption of titanium dioxide nanoparticles, which are less than 100 nm in diameter.